KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 162 filers reported holding KRYSTAL BIOTECH INC in Q1 2023. The put-call ratio across all filers is 1.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,219 | +13.8% | 27,750 | +15.1% | 0.03% | +34.8% |
| Q2 2023 | $2,829 | -74.0% | 24,101 | -82.3% | 0.02% | -74.4% |
| Q1 2023 | $10,899 | +30.1% | 136,141 | +28.7% | 0.09% | -26.2% |
| Q4 2022 | $8,378 | -99.8% | 105,761 | +63.2% | 0.12% | +106.8% |
| Q3 2022 | $4,516,000 | +226.5% | 64,786 | +207.5% | 0.06% | +247.1% |
| Q2 2022 | $1,383,000 | +138.0% | 21,066 | +19.4% | 0.02% | -60.5% |
| Q1 2019 | $581,000 | – | 17,648 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
| Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
| S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
| Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
| Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
| Artal Group S.A. | 412,082 | $32,991 | 1.96% |
| First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
| Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
| Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |